Follow-up | Year 0 | Year 1 | Year 3 | Year 5 |
---|---|---|---|---|
all dc-SSc controls A (n=1513) | ||||
mRSS (mean ± SD) | 15.6 ± 9.9 | 12.8 ± 8.8 | 12.1 ± 8.5 | 12.4 ± 9.0 |
N valid; p-value* | 1242; reference | 594; <0.001 | 361; <0.001 | 299; 0.191 |
DLCO SB (%) (mean ± SD) | 63.2 ± 21.9 | 63.0 ± 21.8 | 61.2 ± 20.0 | 60.7 ± 20.3 |
N valid; p-value* | 872; reference | 455; 0.015 | 256; <0.001 | 216; <0.001 |
BMI (kg/m2) (mean ± SD) | 24.3 ± 4.6 | 24.5 ± 4.8 | 24.2 ± 4.6 | 24.3 ± 4.8 |
N valid; p-value* | 758; reference | 402; 0.577 | 311; 0.971 | 285; 0.417 |
male Scl70+ dc-SSc controls B (n=240) | ||||
mRSS (mean ± SD) | 17.2 ± 9.7 | 14.2 ± 12.0 | 15.9 ± 9.0 | 15.5 ± 9.0 |
N valid; p-value* | 218; reference | 93; 0.050 | 45; 0.581 | 40; 0.957 |
DLCO SB (%) (mean ± SD) | 59.1 ± 21.3 | 58.3 ± 23.7 | 56.7 ± 22.6 | 58.2 ± 25.3 |
N valid; p-value* | 163; reference | 78; 0.135 | 29; 0.192 | 35; 0.032 |
BMI (kg/m2) (mean ± SD) | 25.0 ± 4.5 | 24.8 ± 4.1 | 25.0 ± 3.5 | 25.0 ± 4.1 |
N valid; p-value* | 142; reference | 68; 0.373 | 41; 0.948 | 38; 0.258 |
HSCT SSc (n=79) | ||||
mRSS (mean ± SD) | 17.6 ± 11.5 | 12.1 ± 8.6 | 13.6 ± 8.7 | 11.0 ± 8.5 |
N valid; p-value* | 72; reference | 57; <0.001 | 34; 0.006 | 33; 0.001 |
DLCO SB (%) (mean ± SD); p | 54.6 ± 17.8 | 61.2 ± 21.0 | 55.6 ± 15.6 | 60.0 ± 18.5 |
N valid; p-value* | 55; reference | 47; 0.222 | 24; 0.980 | 20; 0.964 |
BMI (kg/m2) (mean ± SD); p | 22.9 ± 4.1 | 23.0 ± 4.6 | 22.6 ± 3.9 | 22.8 ± 3.6 |
N valid; p-value* | 56; reference | 47; 0.844 | 33; 0.727 | 32; 0.175 |